Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study

被引:20
|
作者
Villa, Pia M. [1 ,2 ]
Marttinen, Pekka [3 ]
Gillberg, Jussi [3 ]
Lokki, A. Inkeri [2 ,4 ,5 ,6 ]
Majander, Kerttu [7 ]
Orden, Maija-Riitta [8 ]
Taipale, Pekka [9 ]
Pesonen, Anukatriina [10 ]
Raikkonen, Katri [10 ]
Hamalainen, Esa [2 ,11 ]
Kajantie, Eero [12 ,13 ,14 ,15 ,16 ,17 ]
Laivuori, Hannele [1 ,2 ,18 ]
机构
[1] Univ Helsinki, Obstet & Gynaecol, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Aalto Univ, Helsinki Inst Informat Technol, Dept Comp Sci, Espoo, Finland
[4] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland
[5] Univ Helsinki, Med & Clin Genet, Helsinki, Finland
[6] Univ Helsinki, Bacteriol & Immunol, Helsinki, Finland
[7] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany
[8] Kuopio Univ Hosp, Obstet & Gynecol, Kuopio, Finland
[9] Suomen Terveystalo Oy, Kuopio, Finland
[10] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland
[11] Univ Helsinki, HUSLAB, Helsinki, Finland
[12] Natl Inst Hlth & Welf, Helsinki, Finland
[13] Natl Inst Hlth & Welf, Oulu, Finland
[14] Oulu Univ Hosp, MRC Oulu, PEDEGO Res Unit, Oulu, Finland
[15] Univ Oulu, Oulu, Finland
[16] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland
[17] Univ Helsinki, Helsinki, Finland
[18] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland
来源
PLOS ONE | 2017年 / 12卷 / 03期
基金
芬兰科学院;
关键词
LOW-DOSE ASPIRIN; PREGNANCY COMPLICATIONS; WOMEN; VALIDITY; REGISTRY;
D O I
10.1371/journal.pone.0174399
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Preeclampsia is divided into early-onset (delivery before 34 weeks of gestation) and late-onset (delivery at or after 34 weeks) subtypes, which may rise from different etiopathogenic backgrounds. Early-onset disease is associated with placental dysfunction. Late-onset disease develops predominantly due to metabolic disturbances, obesity, diabetes, lipid dysfunction, and inflammation, which affect endothelial function. Our aim was to use cluster analysis to investigate clinical factors predicting the onset and severity of preeclampsia in a cohort of women with known clinical risk factors. Methods We recruited 903 pregnant women with risk factors for preeclampsia at gestational weeks 12(+0)-13(+6). Each individual outcome diagnosis was independently verified from medical records. We applied a Bayesian clustering algorithm to classify the study participants to clusters based on their particular risk factor combination. For each cluster, we computed the risk ratio of each disease outcome, relative to the risk in the general population. Results The risk of preeclampsia increased exponentially with respect to the number of risk factors. Our analysis revealed 25 number of clusters. Preeclampsia in a previous pregnancy (n = 138) increased the risk of preeclampsia 8.1 fold (95% confidence interval (CI) 5.711.2) compared to a general population of pregnant women. Having a small for gestational age infant (n = 57) in a previous pregnancy increased the risk of early-onset preeclampsia 17.5 fold (95%CI 2.160.5). Cluster of those two risk factors together (n = 21) increased the risk of severe preeclampsia to 23.8-fold (95%CI 5.160.6), intermediate onset (delivery between 34(+0)-36(+6) weeks of gestation) to 25.1-fold (95%CI 3.179.9) and preterm preeclampsia (delivery before 37(+0) weeks of gestation) to 16.4-fold (95%CI 2.052.4). Body mass index over 30 kg/m(2) (n = 228) as a sole risk factor increased the risk of preeclampsia to 2.1-fold (95%CI 1.13.6). Together with preeclampsia in an earlier pregnancy the risk increased to 11.4 (95%CI 4.520.9). Chronic hypertension (n = 60) increased the risk of preeclampsia 5.3-fold (95%CI 2.49.8), of severe preeclampsia 22.2-fold (95%CI 9.941.0), and risk of early-onset preeclampsia 16.7-fold (95%CI 2.057.6). If a woman had chronic hypertension combined with obesity, gestational diabetes and earlier preeclampsia, the risk of term preeclampsia increased 4.8-fold (95%CI 0.121.7). Women with type 1 diabetes mellitus had a high risk of all subgroups of preeclampsia. Conclusion The risk of preeclampsia increases exponentially with respect to the number of risk factors. Early-onset preeclampsia and severe preeclampsia have different risk profile from term preeclampsia.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Role of Vitamin C in Prevention of Preeclampsia in High-Risk Cases: Randomized Controlled Trial
    Torky, Haitham A.
    Abo-Louz, Ashraf
    Deif, Osama
    Moussa, Asem
    Aly, Rania
    Shata, Atef
    Ragab, Mona
    El-Taher, Osama S.
    Hussein, Ahmed
    [J]. INTERNATIONAL JOURNAL OF CHILDBIRTH, 2021, 11 (01) : 20 - 26
  • [42] Soluble Endoglin for the Prediction of Preeclampsia in a High Risk Cohort
    Maynard, Sharon E.
    Simas, Tiffany A. Moore
    Bur, Lana
    Crawford, Sybil L.
    Solitro, Matthew J.
    Meyer, Bruce A.
    [J]. HYPERTENSION IN PREGNANCY, 2010, 29 (03) : 330 - 341
  • [43] 3.1: Pre-Pregnancy Cardiovascular Risk in Women with Previous Preeclampsia (PET)/Intrauterine Growth Restriction (IUGR)
    A. A. Mahendru
    C. C. Lees
    T. R. Everett
    C. M. McEniery
    I. B. Wilkinson
    [J]. Artery Research, 2011, 5 (4) : 140 - 140
  • [44] Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth
    Smith, Gordon C. S.
    Crossley, Jennifer A.
    Aitken, David A.
    Jenkins, Nicola
    Lyall, Fiona
    Cameron, Alan D.
    Connor, J. Michael
    Dobbie, Richard
    [J]. OBSTETRICS AND GYNECOLOGY, 2007, 109 (06): : 1316 - 1324
  • [45] Screening high-risk population of persistent postpartum hypertension in women with preeclampsia using latent class cluster analysis
    Li, Yuan-Yuan
    Cao, Jing
    Li, Jia-Lei
    Zhu, Jun-Yan
    Li, Yong-Mei
    Wang, De-Ping
    Liu, Hong
    Yang, Hai-Lan
    He, Yin-Fang
    Hu, Li-Yan
    Zhao, Rui
    Zheng, Chu
    Zhang, Yan-Bo
    Cao, Ji-Min
    [J]. BMC PREGNANCY AND CHILDBIRTH, 2022, 22 (01)
  • [46] Screening high-risk population of persistent postpartum hypertension in women with preeclampsia using latent class cluster analysis
    Yuan-Yuan Li
    Jing Cao
    Jia-Lei Li
    Jun-Yan Zhu
    Yong-Mei Li
    De-Ping Wang
    Hong Liu
    Hai-Lan Yang
    Yin-Fang He
    Li-Yan Hu
    Rui Zhao
    Chu Zheng
    Yan-Bo Zhang
    Ji-Min Cao
    [J]. BMC Pregnancy and Childbirth, 22
  • [47] LOW-DOSE ASPIRIN LOWERS RISK OF PREECLAMPSIA IN HIGH-RISK PATIENTS
    Rosenberg, Karen
    [J]. AMERICAN JOURNAL OF NURSING, 2015, 115 (01) : 57 - 57
  • [48] NT-proBNP levels in preeclampsia, intrauterine growth restriction as well as in the prediction on an imminent delivery
    Lafuente-Ganuza, Paula
    Carretero, Fran
    Lequerica-Fernandez, Paloma
    Fernandez-Bernardo, Ana
    Escudero, Ana, I
    de la Hera-Galarza, Jesus M.
    Garcia-Iglesias, Daniel
    Alvarez-Velasco, Rut
    Alvarez, Francisco, V
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (06) : 1077 - 1085
  • [49] Prediction of Preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry
    Audibert, F
    Benchimol, Y
    Benattar, C
    Champagne, C
    Frydman, R
    [J]. FETAL DIAGNOSIS AND THERAPY, 2005, 20 (01) : 48 - 53
  • [50] Angiogenic factors sFlt-1 and PlGF in preeclampsia: Prediction of risk and prognosis in a high-risk obstetric population
    Tardif, C.
    Dumontet, E.
    Caillon, H.
    Misbert, E.
    Dochez, V.
    Masson, D.
    Winer, N.
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2018, 47 (01) : 17 - 21